Overview of the Global Packaging and Labeling CDMO Market
The Global Packaging and Labeling CDMO Market is anticipated to grow at a rate of 9-10% by 2027.
This growth is being driven by increasing demand from original equipment manufacturers (OEMs) to comply with complex regulatory requirements, achieve cost efficiencies, leverage technical expertise, and mitigate operational risks.

Get Free Sample Report: https://meditechinsights.com/packaging-and-labeling-cdmo-market/request-sample/

Additional factors include a rise in global drug production, a growing prevalence of chronic diseases, infectious conditions, and genetic disorders.
Contract Development and Manufacturing Organizations (CDMOs) specializing in packaging offer a wide array of services ranging from product development, clinical and commercial API production, manufacturing of medicinal products, primary and secondary packaging, labeling, sterilization, and distribution.
They also provide tailored packaging solutions to address the specific requirements of complex or high-value pharmaceutical products.

Rising Demand for Environmentally Friendly Packaging and Regulatory Compliance
Sustainability has emerged as a critical focus within the CDMO sector, driving the adoption of eco-friendly packaging and labeling solutions.
For example, in January 2021, Jabil Inc. acquired Ecologic Brands, Inc., a leading sustainable packaging firm, enhancing Jabil’s capabilities in environmentally responsible packaging.
Stringent regulations in healthcare and pharmaceuticals have also elevated the importance of serialization and track-and-trace systems.
Advanced technologies such as QR codes, RFID, tamper-evident seals, and holograms are increasingly integrated to ensure regulatory compliance, enhance supply chain transparency, and prevent counterfeiting.
As CDMOs expand globally, they must navigate distinct regulatory environments and cater to diverse consumer preferences in packaging and labeling.
The COVID-19 pandemic highlighted the need for resilient supply chains, prompting CDMOs to diversify supplier networks and explore localized sourcing to reduce exposure to disruptions.

Strategic Expansions and Technological Upgrades
In October 2022, Aphena Pharma Solutions completed a $20 million expansion and renovation project, including a new 500,000-square-foot facility for solid dose packaging.
This expansion added four high-speed bottling lines and two high-speed blister lines, enhancing Aphena Pharma’s packaging capabilities for solid dosage products.
Similarly, in June 2023, Catalent expanded its OneBio® Suite, an integrated platform covering development, manufacturing, and supply of biologics, including fill/finish, packaging, and clinical supply services.
These strategic initiatives illustrate how CDMOs are investing in state-of-the-art facilities and technological upgrades to meet growing demand and regulatory requirements.

Key Factors Driving Market Growth
The rising geriatric population worldwide is increasing demand for pharmaceutical products, fueling the need for contract packaging services.
Stringent regulatory requirements imposed by global governing agencies drive the adoption of advanced packaging technologies and serialization practices.
Many small and mid-sized companies lack in-house packaging expertise or infrastructure, making outsourcing to CDMOs a cost-effective solution.
Specialty packaging, such as drug delivery devices and blister packaging, is experiencing high demand, further propelling the CDMO market.
Manufacturers seeking innovative, customized packaging with reduced risk and increased operational efficiency are increasingly opting for contract packaging services with experienced partners.

Market Constraints and Challenges
Despite growth opportunities, the packaging and labeling CDMO market faces challenges such as intellectual property concerns, which can hinder collaboration and innovation.
A reduction in FDA approvals in certain developed regions may slow market expansion and affect investment decisions.
Balancing sustainability with cost-effective packaging solutions also presents an ongoing challenge for global CDMOs.
Adapting to rapidly evolving regulatory requirements and addressing cybersecurity risks in serialized and trackable packaging remain significant hurdles for market participants.

Regional Insights
North America is expected to maintain the largest share of the global packaging and labeling CDMO market.
This dominance is due to the presence of leading market players, a well-established regulatory environment, significant R&D investments, and a growing elderly population driving pharmaceutical demand.
The Asia-Pacific region is projected to witness the highest CAGR during the forecast period, driven by technological advancements, increased healthcare spending, and the expanding pharmaceutical and biotech sectors.
Emerging markets in Asia-Pacific are investing heavily in modern packaging technologies and establishing partnerships with global CDMOs to meet increasing healthcare needs.

Competitive Landscape Analysis
Some of the key players operating in the global packaging and labeling CDMO market include:

• Aphena Pharma Solutions

• Eurofins Scientific

• Catalent

• PCI Pharma

• Pfizer CentreOne

• Becton, Dickinson & Co

• Almac Group

• Jabil

• Tecomet

• Integer

Organic and Inorganic Growth Strategies Adopted by Key Players
Market participants are actively expanding their footprint through strategic collaborations, acquisitions, and new product or service launches.
In March 2022, Almac Pharma Services introduced Ultra-Low Temperature Solutions for commercial packaging, labeling, and distribution, catering specifically to Advanced Therapy Medicinal Products (ATMPs).
This service includes just-in-time labeling, packaging, and serialization under ultra-low temperatures ranging from -20°C to -80°C.
In February 2022, Thermo Fisher Scientific launched Patheon Commercial Packaging Services for Cell and Gene Therapies (CGT), integrating GMP storage, serialization, ultracold and cryogenic packaging, and global distribution.
These initiatives demonstrate the growing emphasis on customized solutions that address the unique needs of complex drug products and advanced therapies.

Future Outlook for the Global Packaging and Labeling CDMO Market
The global packaging and labeling CDMO market is poised for sustained growth, supported by increasing investments in pharmaceutical R&D, rising drug manufacturing volumes, and the introduction of advanced packaging technologies.
The growing prevalence of chronic diseases, infectious disorders, and genetic conditions will continue to drive demand for outsourcing packaging and labeling services.
A strong focus on patient safety, sustainability, and regulatory compliance, coupled with aggressive organic and inorganic strategies by market leaders, will further strengthen market expansion in the coming years.
The integration of digital tools, automation, and smart labeling technologies is expected to enhance operational efficiency, reduce errors, and improve overall supply chain resilience in the CDMO sector.

Key Request a free sample copy or view report summary: https://meditechinsights.com/packaging-and-labeling-cdmo-market/request-sample/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.